316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials

Autor: Romero, M. Rios, Danielsson, O., Fornander, T., Nordenskjöld, A., Tenorio, G. Pérez, Tobin, N.P., Nordenskjöld, B.A., Stål, O., Esserman, L., Veer, L.J. Van't, Lindström, L.S.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S346-S346
Databáze: ScienceDirect